Company ProfilePremium

Cannabis Sativa, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Cannabis Sativa, Inc. - Healthcare showcase

Year Founded & Workforce

2005

50 Employees

Industry

Healthcare

Services

Medical Cannabis Market
C

Cannabis Sativa, Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Cannabis Sativa, Inc. Overview

Company Headquarter: Nevada, US

Founded: 2005

Workforce: ~50

Company Working: Cannabis Sativa, Inc. has operations in three divisions: telemedicine, contrast manufacturing, and brand development & marketing of products and services in the CBD and marijuana industries. It operates through its subsidiaries, including Wild Earth Naturals (US), White Rabbit (India), hi Brands International (US), Presto Doctor (US), and iBudtender (Canada). It offers products and services to both businesses and consumers and is a publicly-traded company listed as OTCQB: CBDS. The company’s main operations run through its 51% owned telehealth subsidiary PrestoDoctor. PrestoDoctor is a proprietary online telemedicine platform that gives customers access to physicians to obtain a recommendation for medical marijuana.

Strategy

Cannabis Sativa, Inc. focuses on three divisions: telemedicine (PrestoDoctor), contrast manufacturing (GK Manufacturing), and brand development (hi Brands International); its main operations are conducted through its 51% owned telehealth subsidiary PrestoDoctor. It is making collaborations with various partners in the region. It is developing innovative products to gain a larger customer base.

Company Snapshot

$1.2M

Revenue

50

Employees

2005

Founded

Key Developments

DateApproachDevelopment
March 2021ExpansionCannabis Sativa, Inc. has announced that PrestoDoctor, offers its online medical cannabis card service to patients in Iowa.

Product Offering

  • Cannabis Sativa, Inc.
    • Medical Cannabis Market

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1.2 Mn in 2019 to USD 1.8 Mn in 2021.
Cannabis Sativa, Inc. — By Business Segment
Series (USD Mn)201920202021
Sales1.21.91.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.